Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients

Jaap J. Zwaginga; Bronno van der Holt; Peter A. te Boekhorst; Bart J. Biemond; Mark-David Levin; René van der Griend; Anneke Brand; Sonja Zweegman; Hans F. M. Pruijt; Vera M. J. Novotny; Art Vreugdenhil; Marco R. de Groot; Okke de Weerdt; Elisabeth C. M. van Pampus; Tanja M. van Maanen-Lamme; Shulamiet Wittebol; Martin R. Schipperus; Matthijs H. Silbermann; Peter C. Huijgens; Marleen Luten; Rene Hollestein; Jan A. C. Brakenhoff; Jolanda G. Schrama; Fransje A. A. Valster; Gerjo A. Velders; Harry R. Koene

doi:https://doi.org/10.3324/haematol.2014.110213

Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients

Jaap J. Zwaginga, Bronno van der Holt, Peter A. te Boekhorst, Bart J. Biemond, Mark-David Levin, René van der Griend, Anneke Brand, Sonja Zweegman, Hans F. M. Pruijt, Vera M. J. Novotny, Art Vreugdenhil, Marco R. de Groot, Okke de Weerdt, Elisabeth C. M. van Pampus, Tanja M. van Maanen-Lamme, Shulamiet Wittebol, Martin R. Schipperus, Matthijs H. Silbermann, Peter C. Huijgens, Marleen LutenRene Hollestein, Jan A. C. Brakenhoff, Jolanda G. Schrama, Fransje A. A. Valster, Gerjo A. Velders, Harry R. Koene

Research output: Contribution to journal › Comment/Letter to the editor › Academic

16 Citations (Scopus)

Abstract

-

Original language	English
Pages (from-to)	e90-e92
Journal	Haematologica
Volume	100
Issue number	3
DOIs	https://doi.org/10.3324/haematol.2014.110213
Publication status	Published - 2015

Access to Document

https://doi.org/10.3324/haematol.2014.110213

Cite this

Zwaginga, J. J., van der Holt, B., te Boekhorst, P. A., Biemond, B. J., Levin, M-D., van der Griend, R., Brand, A., Zweegman, S., Pruijt, H. F. M., Novotny, V. M. J., Vreugdenhil, A., de Groot, M. R., de Weerdt, O., van Pampus, E. C. M., van Maanen-Lamme, T. M., Wittebol, S., Schipperus, M. R., Silbermann, M. H., Huijgens, P. C., ... Koene, H. R. (2015). Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients. Haematologica, 100(3), e90-e92. https://doi.org/10.3324/haematol.2014.110213

@article{f3a2bac717614227a27ac4be9c8da196,

title = "Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients",

abstract = "-",

author = "Zwaginga, {Jaap J.} and {van der Holt}, Bronno and {te Boekhorst}, {Peter A.} and Biemond, {Bart J.} and Mark-David Levin and {van der Griend}, Ren{\'e} and Anneke Brand and Sonja Zweegman and Pruijt, {Hans F. M.} and Novotny, {Vera M. J.} and Art Vreugdenhil and {de Groot}, {Marco R.} and {de Weerdt}, Okke and {van Pampus}, {Elisabeth C. M.} and {van Maanen-Lamme}, {Tanja M.} and Shulamiet Wittebol and Schipperus, {Martin R.} and Silbermann, {Matthijs H.} and Huijgens, {Peter C.} and Marleen Luten and Rene Hollestein and Brakenhoff, {Jan A. C.} and Schrama, {Jolanda G.} and Valster, {Fransje A. A.} and Velders, {Gerjo A.} and Koene, {Harry R.}",

year = "2015",

doi = "https://doi.org/10.3324/haematol.2014.110213",

language = "English",

volume = "100",

pages = "e90--e92",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "3",

}

Zwaginga, JJ, van der Holt, B, te Boekhorst, PA, Biemond, BJ, Levin, M-D, van der Griend, R, Brand, A, Zweegman, S, Pruijt, HFM, Novotny, VMJ, Vreugdenhil, A, de Groot, MR, de Weerdt, O, van Pampus, ECM, van Maanen-Lamme, TM, Wittebol, S, Schipperus, MR, Silbermann, MH, Huijgens, PC, Luten, M, Hollestein, R, Brakenhoff, JAC, Schrama, JG, Valster, FAA, Velders, GA & Koene, HR 2015, 'Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients', Haematologica, vol. 100, no. 3, pp. e90-e92. https://doi.org/10.3324/haematol.2014.110213

TY - JOUR

T1 - Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients

AU - Zwaginga, Jaap J.

AU - van der Holt, Bronno

AU - te Boekhorst, Peter A.

AU - Biemond, Bart J.

AU - Levin, Mark-David

AU - van der Griend, René

AU - Brand, Anneke

AU - Zweegman, Sonja

AU - Pruijt, Hans F. M.

AU - Novotny, Vera M. J.

AU - Vreugdenhil, Art

AU - de Groot, Marco R.

AU - de Weerdt, Okke

AU - van Pampus, Elisabeth C. M.

AU - van Maanen-Lamme, Tanja M.

AU - Wittebol, Shulamiet

AU - Schipperus, Martin R.

AU - Silbermann, Matthijs H.

AU - Huijgens, Peter C.

AU - Luten, Marleen

AU - Hollestein, Rene

AU - Brakenhoff, Jan A. C.

AU - Schrama, Jolanda G.

AU - Valster, Fransje A. A.

AU - Velders, Gerjo A.

AU - Koene, Harry R.

PY - 2015

Y1 - 2015

N2 - -

AB - -

U2 - https://doi.org/10.3324/haematol.2014.110213

DO - https://doi.org/10.3324/haematol.2014.110213

M3 - Comment/Letter to the editor

C2 - 25425692

SN - 0390-6078

VL - 100

SP - e90-e92

JO - Haematologica

JF - Haematologica

IS - 3

ER -